1. Home
  2. MCHX vs INKT Comparison

MCHX vs INKT Comparison

Compare MCHX & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCHX
  • INKT
  • Stock Information
  • Founded
  • MCHX 2003
  • INKT 2017
  • Country
  • MCHX United States
  • INKT United States
  • Employees
  • MCHX N/A
  • INKT N/A
  • Industry
  • MCHX Business Services
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • MCHX Consumer Discretionary
  • INKT Health Care
  • Exchange
  • MCHX Nasdaq
  • INKT Nasdaq
  • Market Cap
  • MCHX 84.3M
  • INKT 69.2M
  • IPO Year
  • MCHX 2004
  • INKT 2021
  • Fundamental
  • Price
  • MCHX $1.96
  • INKT $14.62
  • Analyst Decision
  • MCHX
  • INKT Buy
  • Analyst Count
  • MCHX 0
  • INKT 3
  • Target Price
  • MCHX N/A
  • INKT $37.50
  • AVG Volume (30 Days)
  • MCHX 24.6K
  • INKT 40.2K
  • Earning Date
  • MCHX 10-30-2025
  • INKT 11-13-2025
  • Dividend Yield
  • MCHX N/A
  • INKT N/A
  • EPS Growth
  • MCHX N/A
  • INKT N/A
  • EPS
  • MCHX N/A
  • INKT N/A
  • Revenue
  • MCHX $47,534,000.00
  • INKT N/A
  • Revenue This Year
  • MCHX N/A
  • INKT N/A
  • Revenue Next Year
  • MCHX $7.56
  • INKT N/A
  • P/E Ratio
  • MCHX N/A
  • INKT N/A
  • Revenue Growth
  • MCHX N/A
  • INKT N/A
  • 52 Week Low
  • MCHX $1.26
  • INKT $4.56
  • 52 Week High
  • MCHX $2.40
  • INKT $76.00
  • Technical
  • Relative Strength Index (RSI)
  • MCHX 50.62
  • INKT 49.30
  • Support Level
  • MCHX $1.65
  • INKT $14.10
  • Resistance Level
  • MCHX $1.98
  • INKT $16.00
  • Average True Range (ATR)
  • MCHX 0.09
  • INKT 1.05
  • MACD
  • MCHX 0.00
  • INKT 0.04
  • Stochastic Oscillator
  • MCHX 72.57
  • INKT 31.30

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: